EXHIBIT 107
CALCULATION OF FILING FEE TABLE
FORM S-8
(Form Type)
MARVION INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities
CALCULATION OF REGISTRATION FEE
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
| Equity | Common Stock, $0.0001 par value per share | Other | 31,408,394 shares (2) | $0.0144 (3) | $452,280.87 (3) | 0.00015310 | $69.24 |
| Total Offering Amounts | $452,280.87 | $69.24 | |||||
| Total Fees Previously Paid | — | ||||||
| Total Fee Offsets | — | ||||||
| Net Fee Due | $69.24 | ||||||
| (1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (“Registration Statement”) shall also cover any additional shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”), that become issuable in respect of the securities identified in the table above as a result of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration that results in an increase to the number of outstanding shares of the Registrant’s Common Stock. In addition, this Registration Statement registers the resale of shares of the Registrant’s Common Stock by certain selling securityholders identified in the prospectus included in and filed with this Registration Statement, for which no additional registration fee is required pursuant to Rule 457(h)(3) under the Securities Act. |
| (2) | Represents shares of Common Stock issuable pursuant to the Marvion Inc. 2023 Stock Incentive Plan, as amended. |
| (3) | PPursuant to Rule 457(c) and 457(h) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $0.0144 which is the average of the bid and ask prices of shares of the Registrant’s Common Stock on the over-the-counter market (“OTC”) on February 10, 2025. |
